Most Likely Diagnosis: Gastroesophageal Reflux Disease (GERD)
This patient's presentation is classic for GERD, and you should initiate empirical treatment with twice-daily proton pump inhibitor (PPI) therapy for 4 weeks after ensuring cardiac causes have been adequately excluded 1.
Clinical Reasoning
The symptom pattern strongly points to GERD:
- Pain occurs only with eating, never with activity (making cardiac ischemia unlikely)
- Classic heartburn sensation
- Reflux-associated cough
- Right-sided and epigastric chest pain distribution
- No cardiac symptoms (no dyspnea, palpitations, leg edema, or activity intolerance)
The recent dietary change to high protein may have exacerbated reflux by increasing gastric acid production and delaying gastric emptying.
Critical consideration: His stroke history increases his GERD risk by approximately 1.5-fold 2, and antiplatelet medications (aspirin, clopidogrel, or dipyridamole) commonly prescribed post-stroke further elevate GERD risk 2.
Management Algorithm
Step 1: Cardiac Evaluation (Brief but Essential)
Given his stroke history and chest pain, document:
- Pain characteristics confirm non-cardiac pattern (eating-related, not exertional)
- Stable vital signs
- No concerning cardiac symptoms
- If any doubt exists, obtain ECG and consider troponin
Step 2: Empirical PPI Trial
Initiate twice-daily PPI therapy for 4 weeks 1. This is the Grade A recommendation for suspected reflux chest pain syndrome once cardiac etiology has been considered.
- Dosing: Standard PPI (e.g., omeprazole 20mg, lansoprazole 30mg, or esomeprazole 40mg) twice daily
- Take 30-60 minutes before meals
- Duration: 4-week trial minimum
Step 3: Dietary Modifications
- Reduce high-protein meal sizes (smaller, more frequent meals)
- Avoid late-night eating
- Elevate head of bed
- Reduce vitamin C supplements if taken in large doses (can increase gastric acidity)
Step 4: Response Assessment at 4 Weeks
If symptoms resolve: Continue PPI therapy and consider step-down to once-daily dosing for maintenance.
If symptoms persist despite twice-daily PPI: Proceed to diagnostic testing:
- Esophageal manometry (to exclude motility disorders like achalasia or esophageal spasm) 1
- 24-hour pH or impedance-pH monitoring (to document acid exposure and rule out refractory reflux) 1, 3
- Upper endoscopy if not already performed (to evaluate for erosive esophagitis, Barrett's esophagus, or alternative diagnoses) 3
Important Caveats
Pitfall to avoid: Do not perform extensive diagnostic testing before the empirical PPI trial. The guideline explicitly recommends empirical therapy first for suspected reflux chest pain syndrome 1.
Alternative diagnosis consideration: While rumination syndrome can present with postprandial regurgitation 4, this patient's symptom timing (intermittent over 2 weeks, not immediate postprandial) and heartburn make GERD far more likely.
Stroke-specific consideration: Patients with stroke have significantly elevated GERD risk 2, making this diagnosis even more probable in this population. Review his post-stroke medications, as aspirin (HR 2.34), clopidogrel (HR 1.41), and dipyridamole (HR 1.30) all substantially increase GERD risk 2.
Why This Approach
The AGA guideline provides Grade A evidence supporting empirical twice-daily PPI therapy for suspected reflux chest pain syndrome 1. This approach is both diagnostic and therapeutic—symptom resolution confirms the diagnosis while avoiding unnecessary testing. Meta-analyses demonstrate clear benefit from this 4-week trial 1.
Only if this empirical trial fails should you pursue invasive diagnostic procedures, following the algorithmic approach of manometry first (to exclude motility disorders), then pH monitoring (to document refractory reflux) 1.